Get the Stockscreener App
4.21
1.69%
0.07
After Hours:
4.21
Bioharvest Sciences Inc stock is traded at $4.21, with a volume of 18,609.
It is up +1.69% in the last 24 hours and down -1.64% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
See More
Previous Close:
$4.14
Open:
$4.24
24h Volume:
18,609
Relative Volume:
0.79
Market Cap:
$95.43M
Revenue:
$34.51M
Net Income/Loss:
$-11.14M
P/E Ratio:
-6.8511
EPS:
-0.6145
Net Cash Flow:
$-15.39M
1W Performance:
-2.09%
1M Performance:
-1.64%
6M Performance:
-52.43%
1Y Performance:
-33.91%
1-Day Range:
$4.21
$4.33
1-Week Range:
$4.11
$4.465
52-Week Range:
$4.10
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST vs KHC, GIS, JBS, MKC, HRL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
4.21 | 93.84M | 34.51M | -11.14M | -15.39M | -0.6145 |
KHC
Kraft Heinz Co
|
22.54 | 26.54B | 24.94B | -5.85B | 3.66B | -4.9384 |
GIS
General Mills Inc
|
34.55 | 18.37B | 18.37B | 2.22B | 1.65B | 4.0676 |
JBS
Jbs Nv
|
16.24 | 17.04B | 66.64B | 1.80B | 773.23M | 1.7184 |
MKC
Mccormick Co Inc
|
48.49 | 12.91B | 7.11B | 1.65B | 680.40M | 6.1005 |
HRL
Hormel Foods Corp
|
20.93 | 11.37B | 12.14B | 489.00M | 577.53M | 0.8886 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Roth Capital | Buy |
| May-05-25 | Initiated | Craig Hallum | Buy |
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables - TMX Newsfile
BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products - TMX Newsfile
Bioharvest Sciences Inc. Announces Closing of the First Tranche of Its Private Placement - TMX Newsfile
BioHarvest Sciences Inc. Announces Partnership with BOLDT and Summit Strategy Group to Develop a Sustainability Framework and ESG Report - TMX Newsfile
BioHarvest Sciences Inc. Announces a Major Breakthrough in the Growth of Cannabis TRICHOMES across Multiple Strains in Liquid Media - TMX Newsfile
BioHarvest Sciences Announces Record $2 Million Monthly Sales - TMX Newsfile
BioHarvest Sciences Sets May 14 Date for First-Quarter 2026 Results - TipRanks
BioHarvest Sciences Inc. Delivers Record First Quarter Sales Performance of VINIA in Israel - TMX Newsfile
BioHarvest Sciences Appoints Co-Founder Zaki Rakib as New CEO - HarianBasis.co
BioHarvest Sciences (NASDAQ: BHST) schedules Q1 2026 earnings release and webcast - Stock Titan
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026 - TMX Newsfile
Small cap wrap: C3 Metals, Candel Therapeutics, BioHarvest Sciences… - Proactive financial news
Biotechnology company Bioharvest Sciences Inc has announced an important personnel change: co-founder and executive chairman Zaki Rakib will officially assume the role of chief executive officer. - bitget.com
Leadership shift at BioHarvest (NASDAQ: BHST) as co-founder Zaki Rakib becomes CEO - Stock Titan
BioHarvest Sciences names co-founder Rakib as CEO in leadership transition - Yahoo Finance
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy - The Globe and Mail
BioHarvest swaps CEOs, keeps Ilan Sobel on board for consumer growth - Stock Titan
BioHarvest Sciences announces proposed public offering; shares down - MSN
HC Wainwright Issues Negative Estimate for BHST Earnings - MarketBeat
Canna-V-Cell Announces Business Combination with its Controlling Shareholder BioHarvest Ltd. ("Bio Harvest") - TMX Newsfile
HC Wainwright Has Negative Forecast for BHST FY2027 Earnings - MarketBeat
H.C. Wainwright reiterates Buy on BioHarvest Sciences stock By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy on BioHarvest Sciences stock - Investing.com
BioHarvest Sciences Q4 2025 Earnings Call Transcript - MarketBeat
BioHarvest Sciences Inc. common stock (NASDAQ:BHST) Q4 2025 earnings call transcript - MSN
BioHarvest (BHST) Stock Long Term Trade (-0.92%) 2026-04-20Stock Accumulation - Cổng thông tin điện tử tỉnh Lào Cai
Bioharvest Sciences Earnings Call Highlights Growth Momentum - TipRanks
H.C. Wainwright Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $14 - 富途牛牛
Equities Analysts Issue Forecasts for BHST Q1 Earnings - MarketBeat
BioHarvest Sciences (BHST) Expected to Announce Earnings on Thursday - MarketBeat
HC Wainwright Has Bearish Estimate for BHST FY2029 Earnings - MarketBeat
Earnings Beat: Is BioHarvest Sciences Inc subject to activist investor interest2026 Drop Watch & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Aug Final Week: Will BioHarvest Sciences Inc outperform tech stocksTrade Entry Summary & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Is BioHarvest Sciences Inc subject to activist investor interest2026 Decliners & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Gains Report: Is BioHarvest Sciences Inc subject to activist investor interest2026 Decliners & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Published on: 2026-04-11 08:45:21 - baoquankhu1.vn
Is BioHarvest (BHST) Stock Declining | Price at $4.31, Up 0.70%Shared Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
Aug PostEarnings: Can BioHarvest Sciences Inc continue delivering strong returnsEarnings Miss & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Dividend Watch: Is BioHarvest Sciences Inc undervalued by DCF analysis2026 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn
Layoff Watch: Is BioHarvest Sciences Incs ROIC above industry average2026 Volatility Report & Target Return Focused Stock Picks - baoquankhu1.vn
Bond Watch: Does BioHarvest Sciences Inc have strong EBITDA margins2026 Trade Ideas & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Movers: What is BioHarvest Sciences Incs valuation compared to sectorQuarterly Profit Review & Technical Confirmation Alerts - baoquankhu1.vn
Is BioHarvest (BHST) Stock Moving Sideways | Price at $4.31, Down 1.15%Social Trading Insights - Xã Châu Thành
Earnings Recap: Will BioHarvest Sciences Inc benefit from green energy policies2026 Rallies & Safe Capital Investment Plans - baoquankhu1.vn
Is BioHarvest (BHST) Stock Showing Weakness | Price at $4.31, Up 0.70%Institutional Grade Picks - Cổng thông tin điện tử tỉnh Lào Cai
What Does BioHarvest Sciences Inc.'s (NASDAQ:BHST) Share Price Indicate? - Yahoo Finance
BHST Stock Analysis: BioHarvest Sciences Inc. $4.28 Minor Dip Performance Review - Xã Thanh Hà
BioHarvest Sciences (NASDAQ:BHST) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
BioHarvest Sciences Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
BioHarvest Sciences advances sustainable fragrance production with rare plant breakthrough - Proactive financial news
BioHarvest completes stage 1 of rare fragrance plant project By Investing.com - Investing.com South Africa
Bioharvest Sciences Inc Stock (BHST) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.39%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):